- Home
- JSPR vs MKTW Comparison
JSPR vs MKTW Comparison
Compare JSPR & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JSPR | MKTW |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 39.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JSPR | MKTW |
|---|---|---|
| Price | $1.55 | $16.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | $18.13 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 975.8K | 8.5K |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 4.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.55 |
| Revenue | N/A | ★ $342,206,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.39 | $9.08 |
| 52 Week High | $7.19 | $21.74 |
Technical Indicators
Market Signals| Indicator | JSPR | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 55.05 |
| Support Level | $1.51 | $16.37 |
| Resistance Level | $1.66 | $16.28 |
| Average True Range (ATR) | 0.12 | 0.52 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 45.19 | 66.15 |
Price Performance
Historical ComparisonAbout JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.